CAV3 and neoplasm: In 2005, a study reported Cav-3 to be expressed in the more differentiated eRMS and aRMS subsets, thereby configuring this protein as a useful marker to assess the degree of differentiation or detect residual tumor cells that may undergo differentiation following chemotherapy [49].